Key result
Primary malignant pericardial mesothelioma presents with recurrent effusion and rapid progression to fatal heart failure.
Why the study?
Primary malignant pericardial mesothelioma is a rare tumor typically characterized by delayed diagnosis, low treatment response, and poor prognosis.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Documents rare effusion presentation of primary pericardial mesothelioma; extends sparse literature on its delayed diagnosis and prognosis.
Metastases to the heart and pericardium are much more common than primary malignant neoplasms. Primary malignant pericardial mesothelioma is a rare tumor that arises from the mesothelial cells of the pericardium. It is usually characterized by a delayed diagnosis, a low response to treatment, and a poor prognosis with an overall survival up to six months after the onset of symptoms. We report a rare case of a 32-year-old woman with primary pericardial malignant mesothelioma that was diagnosed 4 months after the onset of pericardial effusion as the first clinical manifestation.
No takes yet. Share an insight, caveat, or question.
Farhat et al. (2020) conducted a case report in Primary malignant pericardial mesothelioma (n=1). Thoracoscopic surgical biopsy and palliative chemo-radiotherapy was evaluated on Survival after definitive histopathological diagnosis. Primary malignant pericardial mesothelioma in a 32-year-old woman was diagnosed 4 months after initial pericardial effusion via thoracoscopic biopsy, leading to death from heart failure 4 months later.
Synapse has enriched 10 related papers. Consider them for comparative context: